Valtrex Mega Study
Contents
Valtrex
Valtrex

Related

A
Count
A
Treatments
A
Effects
A
User Variables 2
A
Measurements 5

Tags

Valtrex

Treatment Effectiveness

User reported effectiveness ratings Valtrex for various conditions.

Conditions Major Improvement Moderate Improvement Much Worse No Effect Worse Responses
Chronic Fatigue Syndrome 0% 20% 10% 70% 0% 10
Fibromyalgia 0% 43% 0% 43% 14% 7
Vulvodynia 0% 0% 0% 100% 0% 1

Below is the degree of change seen after Valtrex is higher than average.

Outcomes
of
Below is the change in the listed outcome after is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change in the listed outcome after is higher than average.

Valtrex Info

Property Value
Variable Name Valtrex
Aggregation Method SUM
Analysis Performed At 2020-10-08
Duration of Action 21 days
Filling Value 0
Kurtosis 3.5
Mean 0.83333 count
Median 1 count
Minimum Allowed Value 0 count
Number of Aggregate Predictors 0
Number of Aggregate Outcomes 0
Number of Measurements 5
Number of Measurements (including those generated by tagged, joined, or child variables) 5
Public true
Onset Delay 30 minutes
Standard Deviation 0.40824829046386
Unit Count
User Variables 2
UPC 685987322859
Variable Category Treatments
Variable ID 95733
Variance 0.16666666666667